Stereotaxis (STXS) Non-Current Assets (2010 - 2026)
Stereotaxis' (STXS) quarterly Non-Current Assets came in at $18.0 million in Q1 2026, down 9.04% year-on-year from $19.8 million in Q1 2025, and down 2.17% on a QoQ basis from $18.4 million in Q4 2025.
Stereotaxis (STXS) Non-Current Assets (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Non-Current Assets data on file, last reported at $18.0 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 9.04% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was $74.6 million, a 6.35% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, down 9.28% from the prior year.
- Non-Current Assets for Q1 2026 stood at $18.0 million, down from $18.4 million in the prior quarter.
- Over the last five years, Non-Current Assets for STXS reached as high as $22.1 million in Q3 2024 and fell as low as $7.9 million in Q2 2024.
- Historically, Non-Current Assets has averaged $13.6 million across 5 years, with a median of $10.2 million in 2022.
- Across the five-year window, Non-Current Assets surged 377.76% in 2022 and declined 15.93% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $10.2 million in 2022, then declined by 15.0% to $8.6 million in 2023, then jumped by 134.73% to $20.3 million in 2024, then slipped by 9.28% to $18.4 million in 2025, then decreased by 2.17% to $18.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $18.0 million in Q1 2026, $18.4 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | 18.92 Mn |
| Jun 30, 2025 | 19.27 Mn |
| Mar 31, 2025 | 19.79 Mn |
| Dec 31, 2024 | 20.29 Mn |
| Sep 30, 2024 | 22.12 Mn |
| Jun 30, 2024 | 7.94 Mn |
| Mar 31, 2024 | 8.24 Mn |
| Dec 31, 2023 | 8.64 Mn |
| Sep 30, 2023 | 9.01 Mn |
| Jun 30, 2023 | 9.41 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Dec 31, 2022 | 10.17 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 10.04 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 8.51 Mn |
| Jun 30, 2021 | 2.10 Mn |